The Role of an Implantable Loop Recorder for symptom control in patients with Paroxysmal Atrial Fibrillation: A Tertiary Level Atrial Fibrillation Clinic with Nurse Led Management.

Melissa Harvey0 sites30 target enrollmentStarted: May 30, 2019Last updated: July 15, 2019

Conditions

Trial Snapshot

No summary available.

•Over the age of 18 years and under the age of 75 years.
•- Documented evidence of Paroxysmal Atrial Fibrillation through any type of ECG or Holter monitoring.
•- A high burden of Atrial Fibrillation symptoms reported by the patient (at least monthly).
•- A normal heart structure and normal left ventricular function. Normal LVEF. Normal valves.
•- Subject able and willing to give informed consent and return for all required study follow-up visits

•- Under the age of 18 years and over the age of 75 years.
•- Documented Persistent AF.
•- Documented Atrial Flutter.
•- Documented reversible cause for AF e.g. thyroid disease.
•- Previous cardiac surgery.
•- Structural heart disease.
•- Previous left atrial ablation.
•- Subject has an active systemic infection.
•- A history of unstable angina, previous myocardial infarction or percutaneous intervention.
•- A history of chronic obstructive pulmonary disease or evidence of other significant lung disease.
•- Contraindication for oral anticoagulation.
•- Previous TIA or stroke.
•- Significant congenital heart defect.
•- Evidence of congestive cardiac failure or left ventricular dysfunction.
•- Hypertrophic cardiomyopathy.
•- Abnormal long or short QT interval, signs of Brugada syndrome or Arrhythmogenic right ventricular dysplasia.
•- History of sarcoidosis.
•- History of myxoma.
•- Pregnancy or breastfeeding.
•- Life expectancy less than 2 years.
•- Subject is employed by Medtronic or a close relative of investigators.

Sponsor

Melissa Harvey